argenx SE (ARGX)
After hours:
| Previous Close | 393.42 |
| Open | 395.00 |
| Bid | 387.37 x 100 |
| Ask | 389.05 x 100 |
| Day's Range | 384.45 - 397.18 |
| 52 Week Range | 327.73 - 550.76 |
| Volume | |
| Avg. Volume | 264,491 |
| Market Cap | 23.128B |
| Beta (5Y Monthly) | 0.35 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Insider Monkey
Here’s Why argenx SE (ARGX) Pulled Back 23% in Q4
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. In the fourth quarter, the strategy underperformed the Russell Midcap Growth Index and returned 13.66% (gross) and 13.44% (net) while the index return was -14.55%. In addition, please check […]
- Zacks
Why Argenx's (ARGX) Stock Price Moved Up 11% on Thursday
Argenx (ARGX) surges after a Japanese rival posted disappointing results from a late-stage study on its investigational drug for generalized myasthenia gravis.
- Zacks
Argenx (ARGX) Moves 11.2% Higher: Will This Strength Last?
Argenx (ARGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
